MIP Colostrum powder beside a berry smoothie, gold kiwifruit, strawberries and blueberries on a bright kitchen table.

How Colostrum Supports Digestive Health

Colostrum contains naturally occurring bioactive components that can support the intestinal lining, digestive balance and a healthy gut environment.

Digestive health involves much more than breaking down food. The digestive tract also provides a protective interface between the body and everything that passes through it. Its lining, local immune activity and surrounding gut environment work together to support normal digestion and everyday wellbeing.

Bovine colostrum is the nutrient-rich first milk produced after calving. It naturally contains proteins and bioactive components including immunoglobulins, lactoferrin and growth-related factors that have attracted research interest for their potential roles within the gastrointestinal tract. Rather than acting as a treatment for digestive disease, colostrum is best understood as a nutritional food supplement that may help support the systems involved in normal digestive health.

  • Digestive health depends on the coordinated function of digestion, the intestinal lining and local immune activity.
  • Bovine colostrum contains naturally occurring proteins and bioactive components that have been studied in relation to gastrointestinal health.
  • Research is promising in selected settings, but products, doses and outcomes vary, and colostrum should not be presented as a treatment for digestive disease.

The digestive system turns food into nutrients the body can use, moves material through the gastrointestinal tract and removes what is no longer needed. These processes depend on coordinated movement, digestive secretions, a functioning intestinal lining and the many microorganisms that form part of the gut environment.

A healthy digestive system must perform two seemingly opposite tasks. It allows nutrients and water to pass through the intestinal lining while helping limit the passage of unwanted material. It must also respond appropriately to the many food components and microorganisms encountered every day.

For this reason, digestive wellbeing cannot be reduced to one symptom or one part of the gut. Regular bowel habits and digestive comfort matter, but so do the integrity of the intestinal lining and its relationship with local immune defences. Persistent pain, unexplained changes in bowel habits, bleeding or other concerning symptoms should always be assessed by a qualified healthcare professional.

Colostrum is naturally designed to provide concentrated early nutrition together with protective and growth-related components. Bovine colostrum contains proteins, immunoglobulins, lactoferrin, peptides and growth-related factors. These components do not all act in the same way, and their presence alone does not prove a particular health outcome. Together, however, they help explain why bovine colostrum has become a subject of gastrointestinal research.

Some components may interact locally within the digestive tract. Researchers have also investigated how combinations of colostrum components relate to the intestinal barrier, immune signalling and recovery after gastrointestinal stress. Much of this research is highly specific to the population, product and outcome being studied, so it should not be translated into broad promises for every person taking colostrum.

MIP therefore describes colostrum as part of everyday nutrition not as a medicine or a substitute for diagnosis and treatment.

The intestinal lining forms a selective barrier between the contents of the gut and the rest of the body. A layer of mucus and closely connected intestinal cells helps regulate what passes through, while the lining is continually renewed as part of normal physiology.

Bovine colostrum has been studied in relation to this barrier because it contains a complex mixture of growth-related, immune and antimicrobial components. Reviews describe a credible scientific rationale for investigating colostrum in gastrointestinal settings, while also recognising that laboratory findings, animal studies and human clinical outcomes are different levels of evidence.

Human studies have measured outcomes such as intestinal permeability, markers of intestinal-cell stress and digestive symptoms. Results vary. Some controlled trials and reviews report favourable changes in selected populations, while others find no clear benefit. The intestinal lining is therefore an important area of research, but it should not be described as something colostrum is proven to “seal” or “heal” for every user.

The digestive tract is one of the body’s largest points of contact with the outside environment. It encounters food proteins, microorganisms and other material every day, so barrier function and immune activity must work in close coordination.

Immune cells and signalling processes associated with the gut help distinguish between ordinary dietary or microbial exposure and material that may require a response. The intestinal lining is part of this coordinated defence, while the gut environment also influences how the system functions.

Colostrum contains immune-related components, including bovine immunoglobulins and lactoferrin. It is important not to imply that bovine antibodies simply enter an adult’s bloodstream and become human antibodies. Research interest is directed largely towards their possible local interactions within the gastrointestinal tract and the wider effects associated with colostrum’s combined components.

Research into bovine colostrum and gastrointestinal health includes laboratory studies, animal research, small human trials and broader systematic reviews. This evidence helps researchers understand possible mechanisms and identify settings in which colostrum may be useful, but it does not support a universal digestive-health promise.

A 2024 systematic review examined 22 clinical trials involving 1,427 participants with gastrointestinal diseases. The findings were mixed: some outcomes improved in some studies, while others did not. The authors concluded that the evidence remains limited and that more well-designed controlled trials are needed. An earlier systematic review similarly highlighted wide differences in study populations, outcomes and methodological quality.

These limitations matter because “bovine colostrum” is not one standardised research material. Products may differ according to when the colostrum was collected, which milkings were included, the concentration of IgG and other components, and how the material was processed. A 2023 study measuring IgG, IGF-I and lactoferrin across successive milkings reported that the combined concentration of these bioactive molecules had fallen by approximately 46% in transition milk from the second milking and continued to decline across later milkings.

The amount used in a study is therefore important, but grams alone do not fully describe the intervention. Where possible, MIP articles will report the study dose together with the product’s composition, collection information and processing details. When these are not disclosed, the research product cannot be directly compared with MIP Colostrum.

MIP’s standard adult serving is 2g daily. With batch-verified IgG of 20–25%, this provides approximately 400–500 mg of IgG per serving. This allows the MIP serving to be described accurately, but it does not prove that 2g of MIP Colostrum is clinically equivalent or superior to 10g or 20g of a different product used in a study.

Colostrum is generally used as a regular food supplement rather than as a quick response to an occasional digestive concern. A simple routine is easier to maintain than repeatedly changing the dose, timing or format in search of an immediate effect.

MIP’s standard adult serving is 2 g daily. Powder, capsules and chewables provide different ways to include colostrum according to individual preference. Powder can be mixed into suitable foods and drinks, while capsules or chewables may be more convenient for work or travel.

No single format is inherently best for digestive health. The most practical choice is the one that suits the person and can be taken consistently. People with persistent digestive symptoms, diagnosed gastrointestinal conditions, milk allergy, pregnancy, medication use or other individual concerns should seek appropriate professional advice.

Colostrum changes quickly after calving. The timing of collection, the milkings included and the handling of the raw material all influence its final composition. For this reason, comparing colostrum products only by the number of grams in a serving can be misleading.

MIP Colostrum is produced from fresh, never-frozen New Zealand colostrum collected from the first two milkings. Every batch is verified at 20–25% IgG, providing a consistent and measurable quality standard. It is then offered in powder, capsule and chewable formats so customers can choose the routine that suits them.

These specifications distinguish the quality and consistency of the product. They do not mean that research conducted with another bovine colostrum product automatically proves the same outcome for MIP.

Choose MIP Colostrum in the format that suits you

Complement your daily routine with Omega-3 Krill Oil.

Continue exploring

Related reading

Have a question about MIP Colostrum?

Visit our Frequently Asked Questions or contact the MIP team.

References

  1. Hajihashemi P, et al. Therapeutic effects of bovine colostrum applications on gastrointestinal diseases: a systematic review. Systematic Reviews. 2024;13. doi:10.1186/s13643-024-02489-1.
  2. Rathe M, Müller K, Sangild PT, Husby S. Clinical applications of bovine colostrum therapy: a systematic review. Nutrition Reviews. 2014;72(4):237–254. doi:10.1111/nure.12089.
  3. Chandwe K, Kelly P. Colostrum therapy for human gastrointestinal health and disease. Nutrients. 2021;13(6):1956. doi:10.3390/nu13061956.
  4. Playford RJ, Weiser MJ. Bovine colostrum: its constituents and uses. Nutrients. 2021;13(1):265. doi:10.3390/nu13010265. Note: one author was affiliated with a bovine-colostrum supplier.
  5. Tortadès M, Garcia-Fruitós E, Arís A, Terré M. The biological value of transition milk: analyses of immunoglobulin G, IGF-I and lactoferrin in primiparous and multiparous dairy cows. Animal. 2023;17(7):100861. doi:10.1016/j.animal.2023.100861.

This article provides general nutritional information and is not intended to diagnose, treat, cure or prevent any disease. Individual needs vary. Follow the product label and seek advice from a qualified health professional where appropriate.